Risk of Non-Hematologic Cancer in Individuals With High-Count Monoclonal B-Cell Lymphocytosis

Leukemia - United Kingdom
doi 10.1038/leu.2015.235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Erythrodermic Psoriasis in a Man With Monoclonal B-Cell Lymphocytosis

Cureus
2017English

Association of Elevated Serumfree Light Chains With Chronic Lymphocytic Leukemia and Monoclonal B-Cell Lymphocytosis

Blood Cancer Journal
OncologyHematology
2019English

Chromosome 2p Gain in Monoclonal B-Cell Lymphocytosis and in Early Stage Chronic Lymphocytic Leukemia

American Journal of Hematology
Hematology
2012English

Polyclonal B-Cell Lymphocytosis With Binucleated Lymphocytes (PPBL)

OncoTargets and Therapy
OncologyPharmacology
2008English

Polyclonal B-Cell Lymphocytosis: Report of Three Cases

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2018English

Incidence and Risk of Hematologic Toxicities in Cancer Patients Treated With Regorafenib

Oncotarget
Oncology
2017English

Histopathological and Molecular Features of Persistent Polyclonal B-Cell Lymphocytosis (PPBL) With Progressive Splenomegaly

British Journal of Haematology
Hematology
2009English

Correction: Incidence and Risk of Hematologic Toxicities in Cancer Patients Treated With Regorafenib

Oncotarget
Oncology
2019English

Graft-Versus-Tumor Effect After Allogeneic Stem Cell Transplantation in HIV-Positive Patients With High-Risk Hematologic Malignancies

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy